NP said during a CC last month that the development of a

New Post Public Reply Private Reply Replies (1) Message Board
Evil Rabbit ClosetInvestor #67917
637
Quote:
NP said during a CC last month that the development of a new RO test would take around 4 months. After the RO is completed, blood samples from the target patient population will need to be taken, analyzed and placed in the BLA.


Quote:
NP said himself, publicly, that it would take 4 months to correct the issue with the RO data. Not my words, his. Part of those 4 months will no doubt be required to develop a leronlimab RO test and the remainder to collect samples, test them, and produce the data.


So it's 4 months to develop a new test, then you're saying potentially another 2-8 months after that to gather data and file BLA?

Or 4 months to "correct everything" (RO test and gather data)?

And you wonder why your uber-pessimistic timelines get questioned. Also worth noting you said NP made these comments in October (TWO months ago). By that calculation and your quote above, they might "correct the issue with the RO data" by February.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Jeito Capital Elevates Ksenija Pavletic to General Partner Role

Updated Category News Views 235

Jeito Capital Announces Ksenija Pavletic's Promotion In a significant move, Jeito Capital has proudly promoted Ksenija Pavletic to the role of General Partner. This promotion reinforces the firm's dedication to bolstering its leadership team as it actively expands its portfolio of innovative healthcare companies. A Leader in Healthcare and Investment Ksenija Pavletic...

Continue Reading
Franklin Templeton Canada Implements Fee Cuts for Small Cap Fund

Updated Category News Views 369

Franklin Templeton Canada Announces Fee Reductions Investors in the Franklin ClearBridge Canadian Small Cap Fund will soon benefit from reduced fees. Franklin Templeton Canada has confirmed that the management and administration fees will be lowered by up to 35 basis points across various series of the fund, marking an important move in response to competitive market...

Continue Reading
B2Gold Announces Financial Results and Upcoming Call Details

Updated Category News Views 130

Insights on B2Gold's Upcoming Financial Results B2Gold Corp. (TSX: BTO, NYSE: BTG, NSX: B2G) is set to unveil its fourth quarter and full year 2024 financial results shortly after the closing of North American markets. The specific release date is slated for mid-week, ensuring stakeholders are well-informed of the company’s latest financial standing. Conference Call...

Continue Reading
JD.com Announces Upcoming Financial Results and Call Details

Updated Category News Views 278

Upcoming Financial Results Announcement by JD.com JD.com, Inc. (NASDAQ: JD), a renowned player in supply chain-based technology and services, is gearing up to unveil its unaudited financial results for the third quarter of 2025. The much-anticipated release is set to occur prior to the opening of the U.S. markets on November 13, 2025. Details of the Earnings Conference...

Continue Reading
Exploring Maritime Dynamics: A New Documentary on the South China Sea

Updated Category News Views 309

Documentary Launch on South China Sea Navigation The South China Sea has emerged as a vital pathway for international commerce, bustling with activities that shape regional economies. Recently, the South China Sea Strategic Situation Probing Initiative released a significant Report. This Report comprehensively outlines the navigation and overflight status in the area,...

Continue Reading